Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

The transmembrane receptor protein tyrosine phosphatase DEP1 interacts with p120ctn

Abstract

The receptor-like protein tyrosine phosphatase DEP1, also known as CD148, is expressed predominantly in epithelial cells, in a variety of tumor cell lines, and in lymphocytes. Expression of DEP1 is enhanced at high cell density, and this observation suggests that DEP1 may function in the regulation of cell adhesion and possibly contact inhibition of cell growth. In order to investigate the function of DEP1, substrate-trapping mutants of the phosphatase were used to identify potential substrates. GST-fusion proteins containing the DEP1 catalytic domain with a substrate-trapping D/A mutation were found to interact with p120ctn, a component of adherens junctions. DEP1 also interacted with other members of the catenin gene family including β-catenin and γ-catenin. The interaction with p120ctn is likely to be direct, as the interaction occurs in K562 cells lacking functional adherens junctions and E-cadherin expression. Catalytic domains of the tyrosine phosphatases PTP-PEST, CD45, and PTPβ did not interact with proteins of the catenin family to detectable levels, suggesting that the interaction of DEP1 with these proteins is specific. DEP1 expression was concentrated at sites of cell–cell contact in A549 cells. p120ctn was found to colocalize with these structures. Together these data suggest an important role for DEP-1 in the function of cell–cell contacts and adherens junctions.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8

Similar content being viewed by others

References

  • Aicher B, Lerch MM, Muller T, Schilling J, Ullrich A . 1997 J. Cell Biol. 138: 681–696

  • Anastasiadis PZ, Moon SY, Thoreson MA, Mariner DJ, Crawford HC, Zheng Y, Reynolds AB . 2000 Nat. Cell Biol. 2: 634–637

  • Anastasiadis PZ, Reynolds AB . 2001 J. Cell Sci. 113: 1319–1334

  • Angers-Loustau A, Cote JF, Charest A, Dowbenko D, Spencer S, Lasky LA, Tremblay ML . 1999 J. Cell Biol. 144: 1019–1031

  • Aghib DF, McCrea PD . 1995 Exp. Cell Res. 218: 359–369

  • Baker JE, Majeti R, Tangye SG, Weiss A . 2001 Mol. Cell Biol. 21: 2393–2403

  • Barth AIM, Nathke IS, Nelson JW . 1997 Curr. Opin. Cell Biol. 9: 683–690

  • Behrens J, Vakaet L, Friis R, Winterhager E, Van Roy F, Mareel MM, Birchmeier W . 1993 J. Cell Biol. 120: 757–766

  • Brady-Kalnay SM, Rimm DL, Tonks NK . 1995 J. Cell Biol. 130: 986–997

  • Brady-Kalnay SM, Mourton T, Nixon JP, Pietz GE, Kinxh M, Chen H, Brackenbury R, Rimm DL, Del Vecchio RL, Tonks NK . 1998 J. Cell Biol. 141: 287–296

  • Calautti E, Cabodi S, Stein PL, Mechthild H, Kedersha N, Dotto PG . 1998 J. Cell Biol. 141: 1449–1465

  • Daniel JM, Reynolds AB . 1995 Mol. Cell Biol. 15: 4819–4824

  • Daniel JM, Reynolds AB . 1997 Bioessays 19: 883–891

  • de la Fuente-Garcia MA, Nicolas JM, Freed JH, Palou E, Thomas AP, Vilella R, Vives J, Gaya A . 1998 Blood 91: 2800–2809

  • Fachinger G, Urgan D, Risau W . 1999 Oncogene 18: 5948–5953

  • Flint AJ, Tiganis T, Barford D, Tonks NK . 1997 Proc. Natl. Acad. Sci. USA 94: 1680–1685

  • Fuchs MT, Muller T, Lerch MM, Ullrich A . 1996 J. Biol. Chem. 271: 16712–16719

  • Gaya A, Pirotto F, Palou E, Autschbach F, Del Pozo V, Sole J, Serra-Pages C . 1999 Leuk. Lymphoma 25: 237–243

  • Gumbiner BM . 1995 Curr. Opin. Cell Biol. 7: 634–640

  • Gumbiner BM . 1996 Cell 84: 345–357

  • Hamaguchi M, Matsuyoshi N, Ohnishi Y, Gotoh B, Takeichi M, Nagai Y . 1993 EMBO J. 12: 307–314

  • Jallal B, Mossie K, Vasiloudis G, Knyazev P, Zachwieja J, Clairvoyant F, Schilling J, Ullrich A . 1997 J. Biol. Chem. 272: 12158–12163

  • Keane MM, Lowrey GA, Ettenberg SA, Dayton MA, Lipkowitz S . 1996 Cancer Res. 56: 4236–4243

  • Knudsen KA, Peralta-Soler A, Johnson KR, Wheelock MJ . 1995 J. Cell Biol. 130: 67–77

  • Kovalenko J, Denner K, Sandstrom J, Persson C, Gross S, Jandt E, Vilella R, Bohmer F, Ostman A . 2000 J. Biol. Chem. 275: 16219–16226

  • Kinch MS, Clark G, Der CJ, Burridge K . 1995 J. Cell Biol. 130: 461–471

  • Kypta RM, Su H, Reichardt LF . 1996 J. Cell Biol. 134: 1519–1529

  • Lampugnani MG, Corada M, Caveda L, Breviarioi F, Ayalon O, Geiger B, Dejana E . 1995 J. Cell Biol. 129: 203–217

  • Mariner DJ, Anastasiadis P, Keilhack H, Bohmer F-D, Wang J, Reynolds AB . 2001 J. Biol. Chem. 276: 28006–28013

  • Lampugnani MG, Corada M, Andriopoulou P, Esser S, Risau W, Dejana E . 1997 J. Cell Sci. 110: 2065–2077

  • Matsuyoshi N, Hamaguchi M, Taniguchi S, Nagafuchi A, Tsukita S, Takeichi M . 1992 J. Cell Biol. 118: 703–714

  • Nagafuchi A, Takeichi M, Tsukita S . 1991 Cell 65: 849–857

  • Ostman A, Yang Q, Tonks NK . 1994 Proc. Natl. Acad. Sci. USA 91: 9680–9684

  • Osborne JM, den Elzen N, Lichanska AM, Costelloe EO, Yamada T, Cassady AI, Hume DA . 1998 J. Leukoc. Biol. 64: 692–701

  • Ozawa M, Kemler R . 1998 J. Biol. Chem. 273: 6166–6170

  • Pawlak G, Helfman DM . 2001 Curr. Opin. Gen. Dev. 11: 41–74

  • Reynolds AB, Roesel DJ, Kanner SB, Parsons JT . 1989 Mol. Cell. Biol. 9: 629–638

  • Reynolds AB, Daniel JM, McCrea PD, Wheelock MJ, Wu J, Zhang Z . 1994 Mol. Cell. Biol. 14: 8333–8342

  • Reynolds AB, Herbert L, Cleveland JL, Berg ST, Gaut JR . 1992 Oncogene 7: 2439–2445

  • Rimm DL, Koslov ER, Kebriaci P, Cianci CD, Morrow JS . 1995 Proc. Natl. Acad. Sci. USA 92: 8813–8817

  • Shiozaki H, Oka H, Inoue M, Tamura S . 1996 Cancer 77: 1605–1613

  • Sorby M, Sandstrom J, Ostman A . 2001 Oncogene 20: 5219–5224

  • Stuckey JA, Schuber HL, Fauman EB, Zhang ZY, Dixon JE, Saper MA . 1994 Nature (London) 370: 571–575

  • Staddon JM, Smales C, Schulze C, Esch FS, Rubin LL . 1995 J. Cell Biol. 130: 369–381

  • Takahashi T, Takahashi K, Mernaugh R, Drozdoff V, Sipe C, Schoecklmann H, Robert B, Abrahamson DR, Daniel TO . 1999 J. Am. Soc. Nephrol. 10: 2135–2145

  • Tangye SC, Wu J, Aversa G, de Vries JH, Lanier LL, Phillips JH . 1998a J. Immunol. 161: 3803–3807

  • Tangye SC, Phillips JH, Lanier LL, de Vries JH, Aversa G . 1998b J. Immunol. 161: 3249–3255

  • Zhang ZY, Wang Y, Dixon JE . 1994 Proc. Natl. Acad. Sci. USA 91: 1624–1627

  • Zondag GCM, Reynolds AB, Moolenaar WH . 2000 J. Biol. Chem. 275: 11264–11269

Download references

Acknowledgements

We thank Antoni Gaya and Eduard Palou for their kind gift of DEP1 143-41 antibody, and David Rimm for the p120ctn cDNA clone. We gratefully acknowledge Ron Hill, David Markby, and Audie Rice for comments on the manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Leslie J Holsinger.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Holsinger, L., Ward, K., Duffield, B. et al. The transmembrane receptor protein tyrosine phosphatase DEP1 interacts with p120ctn. Oncogene 21, 7067–7076 (2002). https://doi.org/10.1038/sj.onc.1205858

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1205858

Keywords

This article is cited by

Search

Quick links